Kindeva Drug Delivery

Kindeva is a specialized drug delivery CDMO with a storied history of innovation, including the invention of the pressurized metered-dose inhaler (pMDI). It provides end-to-end services across three core technology platforms: inhalation (pMDIs, DPIs), injectables (autoinjectors, pens), and dermal delivery (patches, microneedles). The company is strategically positioned to capitalize on the growing demand for complex drug-device combinations and is a leader in the transition to environmentally sustainable, low-GWP propellants for inhalers. As a private company, it operates globally with major facilities in the UK and the US.

Specialized drug-device combination platforms across three core modalities: 1) Inhalation (pMDIs with low-GWP propellants, DPIs), 2) Injectables (autoinjectors, dual-chamber devices, pen injectors), and 3) Dermal/Transdermal (patches, solid microneedle arrays).

Kindeva competes in the specialized CDMO space for drug-device combinations against companies like Bespak (Recipharm), Nemera, SHL Medical, and Aptar Pharma. Its historical innovation and deep expertise in inhalation, particularly with sustainable propellants, are key differentiators. It also competes with larger, full-service CDMOs that have device capabilities.